MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Flexion Therapeutics Company Profile (NASDAQ:FLXN)

Consensus Ratings for Flexion Therapeutics (NASDAQ:FLXN) (?)
Ratings Breakdown: 6 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $38.40 (147.26% upside)

Analysts' Ratings History for Flexion Therapeutics (NASDAQ:FLXN)
Show:
DateFirmActionRatingPrice TargetActions
5/27/2016Janney Montgomery ScottReiterated RatingBuy$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/27/2016Needham & Company LLCReiterated RatingBuy$28.00 -> $34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/26/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/3/2016Wells FargoInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/17/2016RBC CapitalReiterated RatingOutperform$44.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/2/2015Northland SecuritiesReiterated RatingBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2015BMO Capital MarketsReiterated RatingOutperform$36.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/30/2015MLV & Co.Initiated CoverageBuy$38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/26/2014Summer StreetReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/30/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha